Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / @xirurgi_2025 / @xirurgi_2025 - 541 - файл

.pdf
Скачиваний:
0
Добавлен:
29.08.2026
Размер:
26 Мб
Скачать
422
hypoproteinemia, chronic diarrhea, electrolyte and micronutrient deciencies, hyperparathyroidism, nephrolithiasis, and gastroesophageal reux disease (GERD). Understanding the mechanisms of malabsorption that occur in all patients undergo­ing DS is paramount to the successful long-term management of these patients. It is therefore essential for patients undergoing malabsorptive operations to understand the need for adherence with a strict follow-up plan.
D. Bahroloomi et al.
46.2 Long-Term andNutritional Complications
Intestinal bypass increases the risk of frequent bowel movements, atulence, ano­rectal pathology, micronutrient deciency, divalent cations, and hypoproteinemia [6]. When assessing the true nutritional status of patients, it is essential to under­stand that patients with morbid obesity often have excess fat but decreased lean muscle and vitamin stores. In fact, these patients can often present nutritionally malnourished with lack of reserve. This state of “high-calorie malnutrition” is due to a preoperative diet that is generally high in processed foods with limited nutri­tional value resulting in inadequate ability to utilize calories efciently [7].
Therefore, postoperative nutritional counseling and monitoring with long-term blood work including total protein, iron, calcium, fat-soluble vitamins, and PTH is essential to the success of the post-surgical patient [8]. During ofce visits, review of systems should include assessment for new onset of numbness, weakness, leth­argy, and the number and consistency of bowel movements. The vast majority of primary BPD-DS and SADI-S patients move their bowels 2–4 times per day and adapt to the surgical procedure with little difculty [8, 9]. Thorough physical exam­ination should include measurement of muscle strength. One simple test is to have the patients stand from a sitting position without assistance from the arms. As the gluteal muscle is one of the largest in the body, it will atrophy early if intake is poor [10].
46.2.1 Anatomic Effects onNutrition
A major concern of the DS is the consequences of shorter bowel length causing diarrhea, perirectal complications, and protein and vitamin deciency. The nutri­tional effects of the DS depend on the length of the alimentary limb and the com­mon channel. The length of the alimentary limb correlates with protein absorption, while increased size of the common channel reduces fat malabsorption [5]. During revision surgery, the common channel is usually elongated, allowing for a longer segment of bowel for absorption of food. Most DS revisions report a 100cm com­mon channel elongation, while Scopinaro recommended a 150 cm increase for BPD [11].
46 Malabsorptive Complications
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
423
In order to further study the etiology of high revision rates after index BPD pro­cedures, Topart etal. conducted a literature review comparing the rate of revisions after DS and BPD [12]. This study demonstrated that the rate of revision was
0.5–4.9% for DS and 3–18.5% for BPD [12]. In their review, the chief reason for reoperation was found to be protein malnutrition, which accounted for 43–60% of the revision procedures [12]. Similarly, Hamoui etal. reported a series of DS requir­ing revision. Results of this series revealed that the most common indications for revision were malnutrition (20/33), diarrhea (9/33), metabolic abnormalities (5/33), abdominal pain (3/33), liver disease (2/33), and emesis (2/33) [13]. The revision surgery was successful for those having the operation to reduce chronic diarrhea, with the median number of daily bowel movements being reduced from 5 to 1 [13]. Almost all patients had improvement in albumin levels to >3.5g/dL except for one patient whose albumin increased from 2.5 to 2.8g/dL [13].
This idea is further demonstrated by Lebel etal. in a study which compared the DS with 200cm common channel vs. 100cm common channel and discovered that the longer channel group had lower severe protein deciency (11% vs. 19%). Furthermore, patients with the longer channel required vitamins A and D supple­mentation (p < 0.05). Patients also had fewer bowel movements (2.0 vs. 2.9, p= 0.03) with no signicant decrease in weight loss [14]. This data suggests that some of the main complications of the DS can be possibly reduced with lengthening the common channel while still maintaining signicant weight loss [14].
46.2.2 Hypoproteinemia
Optimization of protein intake after surgery should be the primary nutritional goal after DS.During periods of rapid weight loss, the body will need to conserve lean body mass to support an increased metabolism and the ability to burn calories. High-quality protein sources increase satiety as well as aid in tissue healing. It is generally recommended that patients consume 80–100g protein/day (1.0–1.5g/kg IBW) [15]. While this high quantity may be difcult to achieve in the rst post­surgical liquid diet phase, protein shakes and liquid supplements are important dietary adjuncts that support this goal. Ideally, protein-rich meals should be distrib­uted throughout the day. In one analysis of patients undergoing DS, Strain etal. found a rate of 7.3% nutritional deciency, 5.1% of which required TPN [2]. At 9years, 30% of patients were protein decient, with 20% of patients having low albumin levels [2].
The most concerning sequelae of hypoproteinemia is extensive peripheral edema. When this occurs, treatment is mandatory. Peripheral and systemic edema are one of the leading indications for revision following BPD-DS and can occur following SADI-S [6]. In severe forms, clinical presentation can be similar to kwashiorkor (edema, hypoproteinemia, anemia, and fatty inltration of the liver) [16]. When assessing a patient with concern for hypoproteinemia, a physical exam can be
424
D. Bahroloomi et al.
notable for swelling in the legs, perineum, abdomen, and upper extremities [16]. These patients are best managed by the use of total parenteral nutrition (TPN) supplementation.
46.2.3 Chronic Diarrhea
The most common theory regarding the etiology of chronic diarrhea following SADI-S or BPD-DS is malabsorption of fat [5]. In reality, multiple synchronous potential causes likely contribute to diarrhea. In addition to malabsorption of fat, partial gastrectomy and increased rate of emptying can exacerbate preexisting lac­tose sensitivity [17]. Carbohydrates that are easily ingested by the intestinal ora can cause bacterial overgrowth, increased fermentation, and watery diarrhea [18]. Subtle protein sensitivities such as to gluten can also become more symptom­atic [17].
The key to diagnosis of factors contributing to chronic diarrhea is the detailed assessment of the patient’s oral intake, characteristic of the stool, and the temporal relationship of intake to bowel movements. For example, fat malabsorption or steatorrhea has been well-documented and characterized by abundant dense stool that oats [19]. However, post-DS patients will always have increased fecal fat in the stool; thus, unless fecal output is monitored with 24-h collection and controlled diet, monitoring of fecal fat is rarely helpful for management. Watery diarrhea fol­lowing a bariatric procedure is more often associated with malabsorption of carbo­hydrates [17]. Lactose deciency presents with frequent watery diarrhea 40min following eating [19]. Additionally, when carbohydrates are poorly absorbed, they enter the colon where they undergo fermentation by bacteria, causing small intes­tinal bacterial overgrowth (SIBO). Buildup of gas (such as methane) contributes to bloating, increased atulence, and reabsorption into the circulation [19]. SIBO can be diagnosed by breath test for lactulose and can be treated with antibiotics [20, 21].
A variety of treatments can help alleviate symptoms of chronic diarrhea. Initial remedies include alteration of diet and the use of motility agents such as Imodium and Lomotil. A histamine-2 blocker and proton pump inhibitor should be pre­scribed.Diet regimens should emphasize a low-fat diet which limits short-chain carbohydrates that are poorly absorbed in the small intestine and more likely to cause fermentation. This regimen is described as the fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) diet [22]. Additionally, increased ber intake and supplementation should be encouraged.If diarrhea per­sists, other medications that have been utilized include clonidine, octreotide, and GLP-1 agonists.The GLP-1 agonists delay gastric emptying and reduce motility [23]. The GLP-2 analogue teduglutide is rarely used following bariatric surgery [24]. Although its use leads to short-term gut hypertrophy and increased absorp­tion, it is expensive and must be used indenitely, or the effect dissipates
46 Malabsorptive Complications
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
425
[24].Therefore, if surgical revision is practical, it is preferred, and the use of GLP-2 analogue is reserved for patients that do not have a surgical alternative [24]. If patients continue to suffer from refractory chronic diarrhea and continued poor nutritional parameters, consideration should be given to surgical reconstruction following nutritional repletion. Nutritional optimization prior to surgery often requires several weeks of parenteral nutrition and can be monitored using prealbu­min levels [25].
46.2.4 Electrolyte Repletion andRefeeding Syndrome
Refeeding syndrome is a potentially life-threatening complication of hasty nutri­tional optimization that can be commonly missed in DS patients who have had sig­nicantly decreased intake for prolonged periods of time [26]. Refeeding syndrome develops when the reintroduction of carbohydrates leads to insulin release and an increase in adenosine triphosphate production, for which phosphate and magnesium are required (magnesium acts as a co-factor) [27]. As a result, potassium and phos­phate are shifted into cells, leading to phosphate depletion that causes an increase in magnesium excretion in the urine [27]. This process results in hypophosphatemia, hypokalemia, and hypomagnesemia that leads to refeeding syndrome [27]. High clinical suspicion should be maintained in bariatric patients, as failure to treat refeeding syndrome can lead to serious multisystem complications, including fatal cardiac arrhythmia, hypoglycemia, and abnormal uid shifts [28].
Treatment of refeeding syndrome begins with hospitalization and gradually increasing calorie infusion via parenteral nutrition. Thiamine must be given prior to administering any high dextrose solution or concentrated feeding. Placement of an enteral feeding tube should be delayed until edema resolves and nutrition improves. With severe hypoalbuminemia, leaky gut is common [29]. Thus, the best approach is the slow initiation of total parenteral nutrition that has 100g of amino acids and 40g of fat and limits dextrose to 140g or less [30]. Synchronously, diuretics can be given with albumin to maintain uid balance and improve peripheral edema [30]. Daily labs including electrolytes should be checked and repleted. When the patient is able to tolerate a diet, calorie counts and number and consistency of bowel move­ments should be recorded.
Often, endoscopy and CT scan are performed to ensure no mechanical cause of decreased intake. Colonoscopy can be considered to assure other synchronous causes such as inammatory bowel disease are not contributing factors. Parenteral administration should be maintained until values are normalized and PO intake improves or there is plan for surgical revision. Whereas outtake issues are resolved with surgery to expand surface areas, intake issues are much more difcult to solve with surgery. Involvement with mental health providers is important. Appetite stim­ulants can be tried. If nutritional status cannot be maintained following resuscita­tion, revision with feeding tube is suggested.
426
D. Bahroloomi et al.
46.2.5 Micronutrient Considerations
Optimizing postoperative patient outcomes and nutrition status begins within the preoperative process. Intensive preoperative nutritional counseling is crucial to gauge patients’ motivation, predicted compliance, and ability to change habits. Patients should be educated before and after surgery on the expected nutrient type, dietary behaviors, and weight loss goals to support long-term outcomes. Invasive alterations to physiology, digestion, absorption, metabolism, and excretion are associated with higher nutrient deciencies and should be reviewed with patients [31].
Laboratory markers are imperative for completing the initial nutrition assess­ment and continued in follow-up care. Baseline values help distinguish between postoperative complications, deciencies related to surgery, and noncompliance with recommended supplementation. Any nutrient deciencies identied pre­surgery should be repleted following the RDA in addition to any individualized recommendations. Common deciencies include the following.
46.2.5.1 Vitamin A
Vitamin A deciency has been reported to be at 52% at 1year and 69% at 4years after DS [32]. Early symptoms of vitamin A deciency are night blindness and changes in conjunctiva of the eyes [32]. Treatment includes 10,000IU PO. Iron, zinc, and protein levels need to be corrected to normalize vitamin A levels [32]. Vitamin A deciency has been found to be associated with low serum prealbumin. Vitamin A levels should especially be monitored in postoperative pregnant patients, and beta-carotene should be used for repletion in this population [33].
46.2.5.2 Calcium andVitamin D
Calcium and vitamin D are important for bone formation, blood coagulation, mus­cle contraction, and myocardial conduction. An acidic environment and adequate levels of vitamin D are needed for proper absorption of calcium and other minerals. Limited intake and/or decreased absorption of one or both can lead to osteopenia, osteoporosis, and/or osteomalacia. While calcium and vitamin D deciencies have higher incidences after malabsorptive procedures, bone mineral depletion directly correlates with the amount of weight lost in an individual, regardless of the cause of weight loss [34]. Calcium citrate supplementation is preferred as it requires mini­mal acid for absorption, and a supplement including magnesium and vitamin D enhances absorption. DS patients require higher calcium doses than other bariatric surgery patients, typically 1800–2400mg divided into doses of 500mg per dose. Vitamin D deciency is prevalent even before weight loss surgery with reports of
46 Malabsorptive Complications
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
427
16–57% [34, 35]. Vitamin D supplementation may consist of up to 50,000 IU weekly for up to 9weeks and 5000IU daily thereafter [36]. Parathyroid (PTH) is the best indicator of calcium status; when PTH increases, bone resorption of cal­cium increases in order to maintain normal blood levels of calcium. It is generally recommended that the PTH level be kept below 100pg/mL to reduce the risk of metabolic bone disease [36]. Bone density should be tracked serially. Blood work should include a minimum of annual albumin, calcium, PTH, and 25-OHD levels to assess bone health. It is important to note that elevated PTH values are commonly found in patients who have had DS or RYGB even with normal vitamin D levels and no change on bone density scans. The signicance is not yet known.
46.2.5.3 Folic Acid
Typically 100mcg of folate is excreted in bile daily; most is reabsorbed in the upper third portion of the unaltered small intestine but may be absorbed throughout the entire small bowel [37]. Since much of the small bowel is bypassed, daily excretion of folate is greater, and deciency may occur rapidly without adequate supplemen­tation of minimum 400mcg daily which can be found in multivitamins [38]. Folate and vitamin B12 are codependent, and deciency of either can contribute to macro­cytic anemia [39].
46.2.5.4 Zinc
Zinc deciency can be suspected with hair loss, poor wound healing, diarrhea, glos­sitis, dermatitis, and hypogeusia [40]. Zinc deciency may arise due to lack of absorption in the proximal jejunum, intolerance to zinc-rich foods such as meat, and fat malabsorption. Supplementing with elemental zinc of 30–50mg daily or every other day may be suggested [40].
46.2.5.5 Iron
Iron deciency anemia is the most common micronutrient deciency following DS [12]. Iron absorption is compromised due to reduced stomach size and less exposure to hydrochloric acid. Furthermore, the principal sites of iron absorption (duodenum and proximal jejunum) are bypassed in the DS [41]. It is important to rule out other causes of anemia, such as deciency of protein, vitamin B12, folate, selenium, zinc, and copper [42]. The 2016 ASMBS Nutritional Guidelines recommend 150–200mg of elemental iron in the form of ferrous fumarate, sulfate, or gluconate for treatment in iron deciency through repletion [43]. If oral supplementation is not effective, intravenous iron infusions containing ferric gluconate may be necessary.
428
D. Bahroloomi et al.
46.2.6 Metabolic Bone Disease
All bariatric procedures that bypass the duodenum and proximal intestine can increase the incidenceof osteomalacia, osteoporosis, osteopenia, and secondary hyperparathyroidism [40]. Calcium absorption is compromised as it is preferen­tially absorbed in the duodenum and proximal jejunum. Vitamin D absorption is hindered by bile diversion.In general, supplements are effective in mitigating dam­age and helping achieve. However, if there is increased malabsorption, then cal­cium will bind to fatty acids increasing the rate of depletion [44]. To normalize, parathyroid hormone will increase recruiting calcium from your bones. Rising PTH reduces phosphate.To minimize the risk of hungry bones, it is essential to optimize calcium and vitamin D [44]. Routine monitoring and serial bone density are suggested.
46.2.7 Nephrolithiasis
Another risk of surgically induced malabsorption is nephrolithiasis.This condition is exacerbated by increases in oxalate circulation postoperatively. In cases of fat malabsorption, calcium will bind to free fatty acids creating a soap-like consis­tency.This environment leaves oxalate free, allowing it to be more freely absorbed by the colon. Oxalate then enters the bloodstream, is ltered by the kidney, and binds to calcium inside the urinary tract.This process can result in stones or calci­nosis of the kidney [31]. Prevention includes a low oxalate diet with appropriate protein intake. Additionally, calcium supplementation is prescribed to improve cal­cium binding to oxalate.Finally, brisk hydration to prevent hypovolemia is essential [31]. Early detection is necessary, as poorly controlled or recurrent nephrolithiasis can progress overlying urosepsis to renal failure.
46.3 Conclusion
The DS is an effective modality for the promotion of weight loss in patients with morbid obesity. The DS has the highest rate of weight loss while bariatric surgeries are performed today but is also associated with the most significant malabsorption and nutrition abnormalities. Important factors to consider in DS patients include chronic diarrhea, electrolyte and micronutrient deficiencies, hyperparathyroidism, nephrolithiasis, and GERD.Understanding the mecha­nisms of malabsorption that occur in all patients undergoing DS is paramount to the successful long-term management of these patients. It is essential for patients undergoing malabsorptive operations to understand the need for adher­ence with a strict follow-up plan.
46 Malabsorptive Complications
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
429
References
1. Moshiri M, Osman S, Robinson TJ, Khandelwal S, Bhargava B, Rohrmann CA.Evolution of bariatric surgery: a historical perspective. Am J Roentgenol. 2013;201(1):W40–8.
2. Strain GW, Ebel F, Honohan J, Gagner M, Dakin G, Pomp A, etal. Comparison of weight loss and body composition changes with four surgical procedures. Surg Obes Relat Dis. 2009;5:582–7.
3. Hess DS, Hess DW, Oakley RS. The biliopancreatic diversion with the duodenal switch: results beyond 10 years. Obes Surg. 2005;15(3):408–16.
4. Buchwald H, Avidor Y, Baunwald E, Jensen M, Pories W, Fahrbach K, etal. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292(14):1724–37.
5. Billeter AT, Fischer L, Wekerle AL, Senft J, Müller-Stich B.Malabsorption as a therapeutic approach in bariatric surgery. Viszeralmedizin. 2014;30(3):198–204.
6. Dorman RB, Rasmus N, al-Haddad B, Serrot FJ, Slusarek B, Sampson B, Buchwald H, etal. Benets and complications of the duodenal switch/biliopancreatic diversion compared to the Roux-en-Y gastric bypass. Surgery. 2012;152(4):758–65.
7. Lonsdale D.Crime and violence: a hypothetical explanation of its relationship with high calo­rie malnutrition. J Adv Med. 1994;7(3):171–80.
8. Marceau P, Hould FS, Simard S, Lebel S, Bourque RA, Potvin M, etal. Biliopancreatic diver­sion with duodenal switch. World J Surg. 1998;22(9):947–54.
9. Elias K, Bekhali Z, Hedberg J, Graf W, Sundbom M. Changes in bowel habits and patient­scored symptoms after Roux-en-Y gastric bypass and biliopancreatic diversion with duodenal switch. Surg Obes Relat Dis. 2018;14(2):144–9.
10. Fischer M, JeVenn A, Hipskind P.Evaluation of muscle and fat loss as diagnostic criteria for malnutrition. Nutr Clin Pract. 2015;30(2):239–48.
11. Scopinaro N, Gianetta E, Civalleri D, Bonalumi U, Lombezzi R, Friedman D, et al. The bilio-pancreatic bypass for functional surgical treatment of obesity. Minerva Med. 1979;70(52):3537–47.
12. Topart PA, Becouarn G.Revision and reversal after biliopancreatic diversion for excessive side effects or ineffective weight loss: a review of the current literature on indications and proce­dures. Surg Obes Relat Dis. 2015;11(4):965–72.
13. Hamoui N, Chock B, Anthone GJ, Crookes PF.Revision of the duodenal switch: indications, technique, and outcomes. J Am Coll Surg. 2007;204(4):603–8.
14. Lebel S, Dion G, Marceau S, Biron S, Robert M, Biertho L.Clinical outcomes of duodenal switch with a 200-cm common channel: a matched, controlled trial. Surg Obes Relat Dis. 2016;12(5):1014–20.
15. Campbell B, Kreider R, Ziegenfuss T, La Bounty P, Roberts M, Burke D, etal. International Society of Sports Nutrition position stand: protein and exercise. J Int Soc Sports Nutr. 2007;4:8.
16. Kushner R.Managing the obese patient after bariatric surgery: a case report of severe malnutri­tion and review of the literature. JPEN J Parenter Enteral Nutr. 2000;24(2):126–32.
17. Hammer HF, Hammer J.Diarrhea caused by carbohydrate malabsorption. Gastroenterol Clin North Am. 2012;41(3):611–27.
18. Jammah AA. Endocrine and metabolic complications after bariatric surgery. Saudi J Gastroenterol. 2015;21(5):269–77.
19. Juckett G, Trivedi R.Evaluation of chronic diarrhea. Am Fam Physician. 2011;84(10):1119–26.
20. Pimentel M, Mayer AG, Park S, Chow EJ, Hasan A, Kong Y. Methane production during lactulose breath test is associated with gastrointestinal disease presentation. Dig Dis Sci. 2003;48(1):86–92.
21. Shah SC, Day LW, Somsouk M, Sewell JL.Meta-analysis: antibiotic therapy for small intesti­nal bacterial overgrowth. Aliment Pharmacol Ther. 2013;38(8):925–34.
22. Whelan K, Martin LD, Satudacher HM, Lomer MCE.The low FODMAP diet in the manage­ment of irritable bowel syndrome: an evidence-based review of FODMAP restriction, reintro­duction and personalisation in clinical practice. J Hum Nutr Diet. 2018;31(2):239–55.
430
23. Parhofer KG.Glucagon-like peptide 1 (GLP-1). MMW Fortschr Med. 2007;149(25):41–3.
24. Jeppesen PB.Teduglutide, a novel glucagon-like peptide 2 analog, in the treatment of patients with short bowel syndrome. Ther Adv Gastroenterol. 2012;5(3):159–71.
25. Beck FK, Rosenthal TC.Prealbumin: a marker for nutritional evaluation. Am Fam Physician. 2002;65(8):1575–8.
26. National Collaborating Centre for Acute Care. National Institute for Health and Clinical Excellence: guidance, in nutrition support for adults: oral nutrition support, enteral tube feed­ing and parenteral nutrition. National Collaborating Centre for Acute Care, UK. 2006.
27. Crook MA, Hally V, Panteli JV. The importance of the refeeding syndrome. Nutrition. 2001;17(7):632–7.
28. Silk Z, Jones L, Heath D.Refeeding syndrome: an important complication after bariatric sur­gery. Surg Obes Relat Dis. 2011;7(5):21–3.
29. Ballinger AB, Farthing MJ.Octreotide in the treatment of intestinal lymphangiectasia. Eur J Gastroenterol Hepatol. 1998;10(8):699–702.
30. Stanga Z, Brunner A, Leuenberger M, Grimble RF, Shenkin A, Allison SP, etal. Nutrition in clinical practice—the refeeding syndrome: illustrative cases and guidelines for prevention and treatment. Eur J Clin Nutr. 2008;62(6):687–94.
31. Cummings S, Pratt J.Metabolic and bariatric surgery: nutrition and dental considerations. J Am Dent Assoc. 2015;146(10):767–72.
32. Slater GH, Ren CJ, Siegel N, Williams T, Barr D, Wolfe B, et al. Serum fat-soluble vita­min deciency and abnormal calcium metabolism after malabsorptive bariatric surgery. J Gastrointest Surg. 2004;8(1):48–55.
33. Slater C, Morris L, Ellison J, Syed AA.Nutrition in pregnancy following bariatric surgery. Nutrients. 2017;9(12):1338.
34. Guney E, Kisakol G, Ozgen G, Yilmaz C, Yilmaz R, Kabalak T.Effect of weight loss on bone metabolism: comparison of vertical banded gastroplasty and medical intervention. Obes Surg. 2003;13(3):383–8.
35. Toh SY, Zarshenas N, Jorgensen J. Prevalence of nutrient deciencies in bariatric patients. Nutrition. 2009;25(11):1150–6.
36. Hamoui N, Anthone G, Crookes PF.Calcium metabolism in the morbidly obese. Obes Surg. 2004;14(1):9–12.
37. Ziegler O, Sirveaux MA, Brunaud L, Reibel N, Quilliot D.Medical follow up after bariatric surgery: nutritional and drug issues. General recommendations for the prevention and treat­ment of nutritional deciencies. Diabetes Metab. 2009;35(6):544–57.
38. Reynolds E.Vitamin B12, folic acid, and the nervous system. Lancet Neurol. 2006;5(1):949–60.
39. Dimopoulos N, Piperi C, Salonicioti A, Vassiliki P, Gazi F, Nounopoulos C, etal. Association of cognitive impairment with plasma levels of folate, vitamin B12 and homocysteine in the elderly. In Vivo. 2006;20(6B):895–9.
40. Bal BS, Finelli FC, Shope TR, Koch TR.Nutritional deciencies after bariatric surgery. Nat Rev Endocrinol. 2012;8:544–56.
41. Herron DM, Roohipour R.Bariatric surgical anatomy and mechanisms of action. Gastrointest Endosc Clin N Am. 2011;21(2):213–28.
42. Mechanick JI, Youdim A, Jones DB, Garvey WT, Hurley DL, McMahon M, et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery. Obesity. 2013;21:S1–S27.
43. Parrott J, Frank L, Rabena R, Craggs-Dino L, Isom KA, Greiman L.American Society for Metabolic and Bariatric Surgery Integrated Health Nutritional Guidelines for the surgical weight loss patient 2016 update: micronutrients. Surg Obes Relat Dis. 2017;13(5):727–41.
44. Kaidar-Person O, Person B, Szomstein S, Rosenthal RJ.Nutritional deciencies in morbidly obese patients: a new form of malnutrition? Part A: vitamins. Obes Surg. 2008;18(7):870–6.
D. Bahroloomi et al.
Chapter 47
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
Postoperative Psychological Assistance
HélioTonelli andAndréiaMinski
47.1 Introduction
Obesity is an important public health problem for which pharmacological, behav­ioral, and surgical treatments are currently available [1]. Biliopancreatic diversion with duodenal switch (BPDDS), along with gastric bypass (RYGBP), is among the surgical techniques leading to weight loss and its maintenance over time [2]. BPDDS includes three specic components: (1) a longitudinal gastrectomy, provid­ing caloric restriction and decreasing acid production while maintaining normal gastric emptying; (2) a 250cm total alimentary limb whose role is to reduce caloric absorption; and (3) a 100cm common channel where the bolus mixes with biliopan­creatic juices, resulting in decreased absorption of protein and fat [3].
As with any surgical technique, BPDDS outcomes are more satisfactory when a patient undergoes regular multidisciplinary follow-up after surgery. Indeed, 20% of bariatric patients achieve <50% excess weight loss after surgery, largely due to psy­chological issues regarding general psychopathology (for instance, depression and anxiety); dysfunctional eating behaviors (DEB) like binges, food addictions, and emotional eating; as well as some personality traits where impulsivity is a central phenomenon [4]. Such conditions need to be properly identied in the preoperative evaluation and treated when they persist despite having been managed before sur­gery, in order to guarantee the best results in terms of weight loss.
H. Tonelli (*) Caetano Marchesini Clinic, Curitiba, PR, Brazil
Neuroscience and Social Cognition at FAE Business School, Curitiba, PR, Brazil
A. Minski Curitiba, PR, Brazil
© The Author(s), under exclusive license to Springer Nature Switzerland AG 2023 A. Teixeira et al. (eds.), Duodenal Switch and Its Derivatives in Bariatric and Metabolic Surgery, https://doi.org/10.1007/978-3-031-25828-2_47
431